Cargando…
Intraocular Pharmacokinetics of 10-fold Intravitreal Ranibizumab Injection Dose in Rabbits
PURPOSE: To investigate intraocular pharmacokinetics of 10-fold dose of intravitreally injected ranibizumab compared with the conventional dose in an experimental model. METHODS: Ranibizumab 30 µL at 10 mg/mL (conventional) and 100 mg/mL (10-fold) doses was injected separately into each eye of 28 ra...
Autores principales: | Kim, Hyeong Min, Park, Young Joo, Lee, Simin, Son, Joo Young, Hong, Hye Kyoung, Ham, Min Hee, Jin, Xuanyou, Chung, Jae Yong, Park, Kyu Hyung, Park, Ki Dong, Woo, Se Joon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396190/ https://www.ncbi.nlm.nih.gov/pubmed/32818095 http://dx.doi.org/10.1167/tvst.9.4.7 |
Ejemplares similares
-
Erratum in: Intraocular Pharmacokinetics of 10-fold Intravitreal Ranibizumab Injection Dose in Rabbits
Publicado: (2023) -
Intraocular Distribution and Kinetics of Intravitreally Injected Antibodies and Nanoparticles in Rabbit Eyes
por: Kim, Hyeong Min, et al.
Publicado: (2020) -
Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab
por: Lee, Jong Wook, et al.
Publicado: (2016) -
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
por: Jung, Byung Ju, et al.
Publicado: (2019) -
Comparison of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Injection: Ranibizumab versus Bevacizumab
por: Hwang, Duck Jin, et al.
Publicado: (2012)